Related Experiment Videos
[Apoptosis modulators]
1Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Vasylkivska 45, Kiev, 03022, Ukraine. apoclub@mail.ru
Biomeditsinskaia Khimiia
|October 18, 2003
Summary
Apoptosis, a key cell death process, is crucial in disease. This review explores novel apoptosis-modulating therapies, including antibodies and small molecules, for enhanced treatment strategies.
Area of Science:
- Biochemistry and Molecular Biology
- Cell Biology
- Pathology
Context:
- Apoptosis (programmed cell death) and necrosis are fundamental cell death mechanisms.
- Dysregulation of apoptosis is implicated in numerous pathological conditions, highlighting its therapeutic relevance.
- Understanding apoptosis pathways is critical for developing targeted interventions.
Purpose:
- To review recent advancements in apoptosis-modulating therapies.
- To discuss the clinical potential of various apoptomodulators, including monoclonal antibodies, proteins, peptides, and small molecules.
- To explore strategies for integrating these therapies with existing treatments.
Summary:
- This review synthesizes current knowledge on apoptosis modulation for therapeutic applications.
- It covers diverse drug classes targeting apoptosis, such as monoclonal antibodies and small molecules.
- The discussion includes the rationale for using these agents to improve standard therapies.
Impact:
- Provides a comprehensive overview of novel apoptosis-targeting drugs.
- Highlights the potential of apoptomodulators to enhance the efficacy of current medical treatments.
- Offers insights into future therapeutic strategies for diseases involving apoptosis dysregulation.